Sugiyama Eri

スギヤマエリ | Sugiyama Eri

Affiliation and department：

Research field (1)： Other

Research theme for competitive and other funds (1)：

2013 - 2016 Development of a novel diagnostic system using next-generation sequencing for targetable gene alterations in lung cancer

Papers (16)：

Shogo Kumagai, Shohei Koyama, Kota Itahashi, Tokiyoshi Tanegashima, Yi-Tzu Lin, Yosuke Togashi, Takahiro Kamada, Takuma Irie, Genki Okumura, Hidetoshi Kono, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer cell. 2022. 40. 2. 201-218
Hibiki Udagawa, Eri Sugiyama, Toshiyuki Harada, Shinji Atagi, Ryo Koyama, Satoshi Watanabe, Yukiko Nakamura, Daijiro Harada, Osamu Hataji, Fumihiro Tanaka, et al. Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR). Translational lung cancer research. 2021. 10. 7. 3059-3070
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, Eri Sugiyama, Hitomi Nishinakamura, Yoshiko Takeuchi, Kochin Vitaly, Kota Itahashi, Yuka Maeda, Shigeyuki Matsui, et al. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nature immunology. 2020. 21. 11. 1346-1358
Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, Sayoko Shinya, Yasuko Tada, Keisuke Kataoka, Kenta Tane, Eiichi Sato, Genichiro Ishii, Koichi Goto, et al. Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer. SCIENCE IMMUNOLOGY. 2020. 5. 43
多根健太, 宇田川響, 桐田圭輔, 杉山栄里, 三好智裕, 青景圭樹, 後藤功一, 坪井正博, 冨樫庸介, 西川博嘉. EGFR-TKIによる腫瘍微小環境の免疫状態の変化. 肺癌. 2019. 59. 6. 691-691

ｍore...

MISC (53)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page